BRNS (Barinthus Biotherapeutics PLC) Net Profit
Barinthus Biotherapeutics (BRNS) develops innovative cancer and hepatitis vaccines, leveraging strategic alliances with Oxford. High patent barriers and strict FDA oversight ensure the protection of its market positions. The development of T-cell therapy depends on R&D success. The company's profit on this chart demonstrates capital efficiency, where the -0.04 mark serves as a relevant indicator of current dynamics.
Analytical breakdowns and data insights for company Barinthus Biotherapeutics plc (BRNS)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Barinthus Biotherapeutics|BRNS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Barinthus Biotherapeutics PLC|BRNS - Company Total Debt|Debts to Book Capitalization Barinthus Biotherapeutics Corp|BRNS - Company Long-Term Debt|Company Short-Term Indebtedness Barinthus Biotherapeutics|Immediate Liquidity barinthusbio.com
- net income and valuation multiples indicators:
Summary company analysis:Barinthus Biotherapeutics
Barinthus Biotherapeutics profit reflects the final financial result after deducting all operating and tax expenses, serving as a key indicator of capital management efficiency. An analysis of the profit generated by the company allows for an assessment of the cash flow stability of Barinthus Biotherapeutics, which remains steady due to the biotech sector's isolation from macroeconomic fluctuations and the constant demand for innovative medical drugs.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR: Company Net Income|NKTR: Net Profit|upstreambio.com (UPB) - Net Profit|Company Net Income Zenas Biopharma|IMNM: Final Profit|Net Profit GOSS|Net Financial Result KalVista Corp|Company Net Income Septerna Inc SEPN|PVLA: Company Profit|SVRA: Net Income|Rigel Pharma - Profit After Payment of Taxes|ANAB: Net Profit|Astria Corp - Final Profit|Net Income ENGN|Net Profit rapt.com|Company Net Income Aerovate Therapeutics Inc (JBIO)|Net Financial Result Aclaris Therapeutics Inc.|Kyverna - Net Income|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|VTYX: Company Net Income|THTX: Net Profit|AVTX - Net Financial Result|Company Net Income Eledon|Company Net Income Agenus, Inc AGEN|Net Income CLYM (Climb Bio Inc)|Profit After Payment of Taxes ZURA|Net Profit ATYR (aTyr Pharma)|Final Profit ADAG|Ikena Oncology, Inc. - Net Profit|Company Net Income Shattuck Labs, Inc.|equilliumbio.com (EQ) - Company Net Income|Connect Biopharma Holdings Limited - Final Profit|IMUX (Immunic Therapeutics) - Net Profit|Net Profit Atara Biotherapeutics Inc|Company Net Income InflaRx N.V. (IFRX)|XFOR: Profit After Tax|Net Profit ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Company Net Income|INMB: Net Income|KZR - Net Profit|SABS (SAB Biotherapeutics, Inc) - Net Income|AKTX: Profit After Payment of Taxes|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Q32 Bio Corp (QTTB) - Net Financial Result|Net Profit GOVX|Net Income Edesa Biotech Inc EDSA|Company Net Income iBio Corp IBIO|Net Financial Result Carisma Therapeutics Inc (CARM)|XTL Biopharmaceuticals - Net Profit|BOLT: Company Net Income|hcwbiologics.com (HCWB) - Company Net Income|Aptevo Therapeutics Inc. - Final Profit|Company Net Income AIM ImmunoTech|Company Profit ADTX (Aditxt Corp)|Company Net Income GRI Bio, Inc. (GRI)|Net Financial Result xortx.com|Company Net Income Vyome Holdings HIND|REVB (Revelation Biosciences Inc) - Profit After Tax|Indaptus - Net Profit|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|Affimed N.V. (AFMD) - Net Profit|Company Net Income Allakos Inc|HOOK: Final Profit|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Net Profit OCEA (Ocean Biomedical, Inc.)|Net Profit tcbiopharm.com TCBP|THRD: Net Income